Astion Pharma A/S
🇩🇰Denmark
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
Phase 2
Completed
- Conditions
- Discoid Lupus Erythematosus
- Interventions
- Drug: ASF 1096 0.5 % creamDrug: ASF 1096 placebo cream
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2008-02-29
- Lead Sponsor
- Astion Pharma A/S
- Registration Number
- NCT00625157
- Locations
- 🇩🇰
Gregor Jemec, Roskilde Hospital, Denmark
Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Phase 2
Completed
- Conditions
- Discoid Lupus Erythematosus
- Interventions
- Drug: Cream vehicle for ASF 1096 cream applied twice dailyDrug: ASF 1096 0.5 % cream applied twice daily
- First Posted Date
- 2008-02-28
- Last Posted Date
- 2008-02-29
- Lead Sponsor
- Astion Pharma A/S
- Target Recruit Count
- 32
- Registration Number
- NCT00625521
- Locations
- 🇸🇪
Filippa Nyberg, Danderyd Stockholm, Sweden
Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis
- First Posted Date
- 2007-11-29
- Last Posted Date
- 2008-06-03
- Lead Sponsor
- Astion Pharma A/S
- Target Recruit Count
- 300
- Registration Number
- NCT00565279
© Copyright 2025. All Rights Reserved by MedPath